NCT03246152View on ClinicalTrials.gov

Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

December 24, 2018

Study Completion Date

December 24, 2018

Conditions

Diabetic Macular EdemaIschemic Maculopathy

Interventions

DRUG

Bevacizumab

Repeated intravitreal injections of Bevacizumab monthly

Trial Locations (1)

Unknown

Cairo University Faculty of Medicine, Cairo

All Listed Sponsors

lead

Cairo University

OTHER

NCT03246152 - Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA | Biotech Hunter | Biotech Hunter